Cognitive Impairments in Stroke: Potential for Medication-Based Correction
- 9 Downloads
Objective. To assess the efficacy and safety of Cellex for the correction of cognitive disorders in the acute period of ischemic stroke (IS). Materials and methods. The study included 246 patients in the acute period of IS. Patients were divided by random selection into two groups given Cellex or placebo for 10 days on the background of standard basal treatment. Patients were assessed dynamically in terms of neuropsychological status. Results and conclusions. This study showed that in patients with IS, mild and moderate cognitive impairments underwent faster and more marked regression when Cellex was prescribed (p < 0.05).
Keywordsischemic stroke cognitive disorders neuroprotection treatment Cellex
Unable to display preview. Download preview PDF.
- 1.M. V. Putilina, “Citicholine in the correction of vascular cognitive impairments in the prophylaxis of post-stroke vascular dementia,” Lech. Vrach, 11, 66–69 (2011), http://www.lvrach.ru/2011/11/15435306, acc. Aug. 28, 2015.
- 4.I. S. Preobrazhenskaya, “Post-stroke cognitive disorders: causes, clinical features, treatment,” Farmateka, 9, 49–53 (2013), http://www.bionika-media.ru/files/uploads/pharmateca/PDF/262/49-53.pdf, acc. Aug. 28, 2015.
- 5.M. A. Cherdak and V. A. Parfenov, “Cognitive disorders in patients with ischemic stroke: a review,” Nevrol. Zh., 16, No. 6, 37–44 (2011), http://www.medlit.ru/j/nev/nj110637.htm, acc. Aug. 28, 2015.
- 6.C. S. Ivan, S. Seshadri, A. Beiser, et al., “Dementia after stroke: the Framingham Study,” Stroke, 35, 1264–1268 (2004), doi: https://doi.org/10.1161/01.str.0000127810.92616.78.CrossRefPubMedGoogle Scholar
- 7.N. V. Shakhparonova and A. S. Kadykov, “Post-stroke cognitive impairments. Potential for drug-based correction using Citicholine (ceraxon),” Atmosf. Nerv. Bol., 2, 16–19 (2011), http://www.atmosphere-ph.ru/modules/Magazines/articles/nervo/an_2_2011_16.pdf, acc. Aug. 28, 2015.
- 8.V. V. Zakharov and N. V. Vakhnina, “Cognitive impairments in cerebrovascular diseases,” Nevrol. Psikhiatr., No. 1, 36–43 (2014), http://noopept.ru/themes/m/docs/6.pdf, acc. Aug. 28, 2015.
- 9.N. V. Vakhnina, “Vascular cognitive impairments,” Nevrol. Neiropsikhiatr. Psikhosom., No. 1, 74–79 (2014), doi: 10.14412/2074-2711-2014-1-74-79.
- 12.Y. Dong, V. K. Sharma, B. P. Chan, et al., “The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for detection of vascular cognitive impairment after acute stroke,” J. Neurosci., 299, No. 1–2, 15–18 (2010), doi: https://doi.org/10.1016/j.jns.2010.08.051.Google Scholar
- 13.N. V. Pizova, “Characteristics of cognitive disorders after stroke: diagnosis and therapeutic approaches,” Nevrol. Neiropsikhiatr. Psikhosom., No. 2, 56–61 (2013), nnp.ima-press.net/index.php/nnp/article/download/211/214, acc. Aug. 28, 2015.
- 14.N. G. Kataeva, N. A. Kornetov, E. V. Karavaeva, et al., “Cognitive impairments after stroke,” Nevrol. Neiropsikhiatr. Psikhosom., No. 1, 37–41 (2010), doi: 10.14412/2074-2711-2010-68.